Prenatal Caffeine Disrupts Sertoli Cells via GR/P300/miR-199a-5p/WT1 Pathway

Prenatal caffeine exposure disrupts testicular Sertoli cell development and impairs offspring reproductive function by altering key signaling pathways.

Previous studies established that prenatal caffeine exposure impairs the function of testicular Leydig cells in offspring. However, the specific impact on supporting Sertoli cells remained unclear until researchers investigated inhibited Wilms tumor 1 expression in testicular Sertoli cells.

Pregnant Wistar rats were orally administered with caffeine at doses of 30, 60, and 120 mg/kg·d from gestational day 9 to 20. The treatment led to abnormal testicular morphology and decreased expression of Sertoli cell development marker genes, specifically Wt1 and Sox9, in offspring.

After birth, the secretory function of the Sertoli cells was impaired, showing reduced levels of androgen-binding protein and inhibin-beta. The expression of blood-testis barrier constituents, including connexin 43, also decreased significantly.

  • Cellular Impact: Caffeine consumed during pregnancy affects the genes responsible for developing essential cells in the male reproductive system.
  • Secretory Decline: Key proteins and barrier components required for normal sperm development show reduced activity after birth.
  • Signaling Pathways: Molecular experiments point to specific receptor and microRNA interactions driving these developmental changes.

Prenatal caffeine exposure increased sperm deformity and reduced sperm motility at postnatal week 12. Chronic stress reduced sperm count and worsened sperm abnormalities in the exposed offspring.

Under experimental conditions, corticosterone reduced the expression of several Sertoli cell markers in TM4 cells. Direct caffeine treatment, conversely, did not significantly change the messenger RNA levels of these markers.

The molecular and cell intervention experiments support a potential role for the GR/P300/miR-199a-5p/WT1 signaling pathway in the Sertoli cell changes associated with prenatal caffeine exposure.

Experimental Parameter Observation Associated Marker or Metric
Gestational Exposure Doses of 30, 60, and 120 mg/kg·d from GD 9 to 20 Abnormal testicular morphology
Developmental Markers Decreased expression in offspring Wt1 and Sox9
Secretory Function Impaired post-natal output Reduced ABP and INH-β
Barrier Integrity Decreased constituent expression Cx43
Offspring Sperm Quality Impaired at PW12 Increased deformity and reduced motility
Photo of author

Health Desk

Health Desk at Archyde.

Billy Evans Secures Profit Share for Charity